Delivery Order SPE2DB24D2101-SPE2DB25FKNJL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,965.76 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $19,093.44 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in endocrinology treatment. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents performance from AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $20,024.51 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. The award, issued on August 18, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of August 19, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $63,498.76 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, which was not set-aside, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $47,064.36 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. This firm fixed-price, non-competitive delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of the vendor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,300.77 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price arrangement. This award was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside delivery order. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for $36,845.12 to supply Sandostatin LAR Depot 30 mg kits. This is a firm fixed-price, non-set-aside contract with a completion date of August 19, 2025, and performance at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $14,482.98 contract is for the supply of 4563433602 - Sandostatin LAR Depot 20 MG Kits, with a completion date of January 25, 2024. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract to provide pharmaceuticals and medical supplies to support DLA...
- The Defense Logistics Agency awarded a $159,383.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNJLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,979.46 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This firm fixed-price, non-competitive delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's DLA prime vendor contract encompasses delivery of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This particular delivery order for Sandostatin LAR Depot reflects the company's ongoing role in fulfilling specialized pharmaceutical needs within the federal medical supply chain, demonstrating its capability to meet time-sensitive procurement requirements for the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 8/12/25 |